Your browser doesn't support javascript.
loading
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis.
Gu, Shuyan; Hu, Xiaoqian; Shi, Lizheng; Zhen, Xuemei; Sun, Xueshan; Huang, Minzhuo; Gu, Yuxuan; Dong, Hengjin.
Afiliação
  • Gu S; Center for Health Policy and Management Studies, School of Government, Nanjing University, Nanjing 210023, China.
  • Hu X; College of Politics and Public Administration, Qingdao University, Qingdao 266071, China.
  • Shi L; Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.
  • Zhen X; Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine (NHC Key Laboratory of Health Economics and Policy Research), Shandong University, Jinan 250012, China.
  • Sun X; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Huang M; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Gu Y; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Dong H; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
J Clin Med ; 11(23)2022 Nov 30.
Article em En | MEDLINE | ID: mdl-36498669

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China